Tang Capital Management »

Seer Cl A Ord shares owned by Tang Capital Management

Quarter-by-quarter ownership of Seer Cl A Ord (SEER) shares owned by Tang Capital Management from 13F filings

Historical chart of Tang Capital Management investment in Seer Cl A Ord

Tip: Access up to 7 years of quarterly data

All positions including Seer Cl A Ord held by Tang Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seer Cl A Ord by Tang Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.9M 2.3M 1.68
2024-03-31 $1.3M 674k 1.90

More positions owned by Tang Capital Management

Tarsus Pharmaceuticals (TARS)
Evolus (EOLS)
Kalvista Pharmaceuticals (KALV)
Mirum Pharmaceuticals (MIRM)
Anaptysbio Inc Common (ANAB)
Biosante Pharmaceuticals (ANIP)
Dynavax Technologies Corp Com New (DVAX)
Eli Lilly & Co. (LLY)
ACADIA Pharmaceuticals (ACAD)
Vaxcyte (PCVX)
Ptc Therapeutics I (PTCT)
Intra Cellular Therapies (ITCI)
Altimmune Com New (ALT)
Miragen Therapeutics (VRDN)
Avadel Pharmaceuticals Com Shs (AVDL)

View all positions for Tang Capital Management

Top funds holding Seer Cl A Ord

Softbank Group Corp
Artal Group
BlackRock
Vanguard Group
Tang Capital Management
Acadian Asset Management
Citigroup
Millennium Management
Renaissance Technologies
Kent Lake Capital
Jacobs Levy Equity Management
D. E. Shaw & Co
Goldman Sachs Group
Two Sigma Advisers
Geode Capital Management

View all funds holding Seer Cl A Ord